H.626

An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Sponsors: Rep. George Till

Location: House Committee on Health Care

Last Recorded Action: 1/10/2020 - Read First Time and Referred to the Committee on Health Care

Committee Activity - Witnesses Who Testified

Regular Session 2019-2020